Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

668 results about "Vinylbital" patented technology

Vinylbital, also known as butylvinal, is a sedative hypnotic drug which is a barbiturate derivative. It was developed by Aktieboleget Pharmacia in the 1950s.

Application of vinyl silicone oil containing hydroxyl groups at terminal as release force regulator to preparation of release agent, release agent and release film

The invention belongs to the technical field of release force regulators, discloses an application of vinyl silicone oil containing hydroxyl groups at terminal as a release force regulator to preparation of a release agent, the release agent and a release film and particularly provides an application to preparation of an addition type organosilicon release agent. According to the application of the vinyl silicone oil containing the hydroxyl groups at the terminal as the release force regulator to preparation of the release agent, the structural formula of the vinyl silicone oil containing the hydroxyl groups at the terminal is shown in the description, wherein n and m represent constitutional repeating units, n ranges from 1 to 10, and m ranges from 0 to 6. The vinyl silicone oil containing the hydroxyl groups as the regulator contains double functional groups, namely, the hydroxyl groups and vinyl groups, thereby having double functions when applied to the release agent, substrate bonding firmness is enhanced by the hydroxyl groups, surface tension of the material is improved by introduction of the hydroxyl groups, the vinyl groups participate in hydrosilylation, compatibility with the release agent is enhanced, the release film with remarkably improved release force can be obtained, and the higher the content of the vinyl silicone oil is, the higher the release force of the release film is.
Owner:国科广化(南雄)新材料研究院有限公司 +2

Monolithic column, preparation method and application thereof

The invention discloses a monolithic column, a preparation method and a application thereof. The preparation method comprises the following steps: 1) polymeric monomer, pore-foaming agent, initiator and cuprous bromide are mixed together and then added with catalyst ligand after being deoxidized; the mixture is put into a chromatographic column tube to react in a sealing way; after the reaction, the chromatographic column tube is connected with a high pressure transfer pump, and the soluble substances such as the pore-foaming agent and the like are rinsed and removed by organic solvent, so that a monolithic column with a three-dimensional continuous skeleton structure is obtained; 2) the mixture of the organic solution, catalyst, catalyst ligand and antioxidant of the functional monomer is injected into the monolithic column, and bromine group remained on the surface of the column body initiates the surface grafting polymerization reaction of vinyl monomer. The method leads polymerization reaction to be carried out at the room temperature, so as to greatly solves the problems of inhomogeneous column body structure, volume contraction and the like caused by high polymerization temperature. Compared with the traditional monolithic column, the obtained monolithic column has obviously different structure, thus being applicable to separating biological macromolecules such as steroid hormone drugs, protein or the like.
Owner:INST OF CHEM CHINESE ACAD OF SCI

IDO restrainer containing (E)-4-(beta-bromo vinyl)benzoyloxy structure

The invention belongs to the technical field of new drug synthesis, and in particular relates to an IDO inhibitor containing (E)-4-(beta-bromovinyl)phenoxy acyl structure, as well as a preparation method thereof. The preparation method comprises the following steps: solvent benzene, (E)-4-(beta-bromovinyl) phenol, carboxylic acid and p-dimethylaminopyridine are added to a flask respectively and magnetically stirred for 5 to 20 minutes at room temperature; then N, N'-dicyclohexylcarbodiimide is added and reacts for 2 to 24 hours at room temperature; after the reaction is completed, the solvent benzene is steamed off after decompression; residue is subjected to column chromatography separation and purification by taking ethyl acetate/petroleum ether as leacheate, and then a needed product can be obtained, wherein the molar ratio of the solvent benzene to the (E)-4-(beta-bromovinyl) phenol is 50-200:1; the molar ratio of the carboxylic acid to the (E)-4-(beta-bromovinyl) phenol is 1-1.5:1; the molar ratio of the p-dimethylaminopyridine to the (E)-4-(beta-bromovinyl) phenol is 0.1-1.5:1; and the molar ratio of the N, N'-dicyclohexylcarbodiimide to the (E)-4-(beta-bromovinyl) phenol is 1-1.2:1. The method takes the (E)-4-(beta-bromovinyl) phenol as a synthesis building block and obtains a series of the novel IDO inhibitors containing the (E)-4-(beta-bromovinyl)phenoxy acyl structure through esterification reaction, and the IDO inhibitors can be used for treating the diseases with the pathological features of IDO mediated tryptophan metabolic pathway.
Owner:SHANGHAI TIANCI BIOLOGICAL VALLEY BIOLOGICAL ENG

Preparation method of chloramphenicol molecular imprinted adsorbing material on surface of magnetic carbon microsphere

The invention relates to a preparation method of a chloramphenicol molecular imprinted adsorbing material on the surface of a magnetic carbon microsphere. The magnetic carbon microsphere is prepared from shaddock peel by adopting a solvent thermal synthesis method, the surface of the magnetic carbon microsphere is subjected to ethylene functional modification by KH570, the treated magnetic carbon microsphere is used as a matrix material, chloramphenicol is used as a template, hydroxyethyl methylacrylate and 4-vinylpyridine are used as functional monomers, N-isopropyl acrylamide is used as a thermosensitive monomer, ethylene glycol dimethacrylate and N,N-methylene bisacrylamide are used as cross-linking agents, 2,2'-azobis[2-methylpropionamidine] dihydrochloride is used as an initiator, and the magnetic carbon microsphere surface imprinted thermosensitive adsorbing material is prepared in a methanol/water mixed system, and the adsorbing material is used for selective recognition and selective separation of chloramphenicol in a water environment. The prepared molecular imprinted adsorbing material on the surface of the magnetic carbon microsphere is low in cost, can be prepared easily, has the high recognition and selectivity properties, high separation and enrichment ability and high adsorption rate of target molecules, and is high in adsorption speed.
Owner:HENAN UNIV OF URBAN CONSTR

Preparation method of microzyme magnetic blotting composite microsphere adsorbent

The invention relates to a preparation method of a microzyme magnetic blotting composite microsphere adsorbent, and belongs to the technical field of environmentally-friendly functional material preparation. The method comprises the following steps: preparing ferriferrous oxide nanoparticles through a coprecipitation process, carrying out hydrophobic modification on the surface of the nanoparticles, preparing a stable Pickering emulsion with an oleic acid modified microzyme aqueous solution as a water phase, cyhalothrin as a template molecule, methacrylic acid and 4-vinylpyridine as functional monomers, ethylene glycol dimethacrylate as a cross-linking agent, dimethyl 2,2'-azobis(2-methylpropionate) as an initiator and hydrophobic Fe3O4 as an oil phase, and carrying out thermal-initiated polymerization to prepare the microzyme magnetic blotting composite microsphere adsorbent. Blotting microspheres obtained in the invention have a good magnetic stability, and the adsorption balance, the dynamics and the selection identification performance of the adsorbent are researched through static state adsorption experiments. Results show that the blotting adsorbent prepared in the invention has a good adsorption capacity, fast adsorption kinetics, and has a selection identification performance on LC.
Owner:JIANGSU UNIV

Methods of producing water-soluble, non-turbid copolymers of at least one water-soluble N-vinyllactam and at least one hydrophobic comonomer

ActiveUS7629425B2Simple methodSolution clarificationPolymer scienceOrganosolv
Methods of producing vinyllactam copolymers which include: providing at least one water-soluble N-vinyllactam; providing at least one hydrophobic comonomer; and subjecting the at least one water-soluble N-vinyllactam and the at least one hydrophobic comonomer to free-radical polymerization in an organic solvent in the presence of an initiator, under a combination of process measures selected from the group consisting of A and B; wherein:(A) comprises (i) polymerization under reflux, and at least two of (ii), (iii), (iv), (v), (vi), and (vii), wherein (ii) comprises an addition of at least 5 mol % of N-vinyllactam to the polymerization mixture if at least 70 mol % of the total amount of hydrophobic monomer used have completely reacted, (iii) comprises return of condensate formed in the reflux from below to the polymerization mixture, (iv) comprises introduction of the initiator in the form of a solution in an organic solvent from below into the polymerization mixture, (v) comprises addition of N-vinyllactam to the reflux, (vi) comprises distilling off a portion of the organic solvent and continuing the polymerization following conversion of 70 to 99% by weight of the N-vinyllactam used, and (vii) comprises introduction of at least one monomer from below into the polymerization mixture; and wherein(B) comprises (viii) polymerization under a superatmospheric pressure such that vaporization of the polymerization components is avoided, and at least one of (i), (ii), (iii), (iv), (v), (vi), and (vii), with the proviso that a combination of (viii) with any of (i), (iii) or (v) is carried out sequentially.
Owner:BASF SE

Synthesis method of anagliptin

The invention relates to a synthesis method of bulk drug of anagliptin for treating II type diabetes, and aims to solve the problem that at present there is no industrial synthesis method of anagliptin. The synthesis method comprises the following steps: (1) taking vinyl ethyl ether and trichloroacetic chloride as the raw materials, carrying out three-step reactions to obtain an intermediate (4) with a protected aldehyde group; carrying out dehydration condensation between the intermediate (4) and 3-amino-5-methylpyrazole to obtain pyrazolopyrimidine parent nucleus; and hydrolyzing carboxyl ethyl ester to obtain 2-methyl-pyrazolo[1,5-a]pyrimidine-6-carboxylic acid6; (2) taking L-proline as the raw material, subjecting L-proline to methyl esterification, ammoniation, acetylation, and cyaniding reactions to obtain a chiral cyanopyrrole intermediate (11); making the chiral cyanopyrrole intermediate (11) and a diamine segment (12) carry out nucleophilic substitution reactions under an alkaline condition to obtain an intermediate (13), and finally removing the Boc protective group from the intermediate (13) in the presence of hydrochloric acid to obtain a cyanopyrrole amine intermediate (14); (3) coupling 2-methyl-pyrazolo[1,5-a]pyrimidine-6-carboxylic acid 6 with the cyanopyrrole amine intermediate (14) under condensation conditions so as to obtain the bulk drug anagliptin.
Owner:南通佰康生物医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products